1. Companies

  2. Sharp Peptide Biotechnology (Dalian) Group

Sharp Peptide Biotechnology (Dalian) Group

Sharp Peptide Biotechnology (Dalian) Group

Launch date
Market cap
-
Enterprise valuation
CAD22—33m (Dealroom.co estimates May 2023.)
Dalian Liaoning (HQ)
    • Edit
DateInvestorsAmountRound
*

$4.0m

Series A
Total FundingCAD5.5m

Recent News about Sharp Peptide Biotechnology (Dalian) Group

Edit